Don't miss this opportunity to learn about reproducibility from the experts at the Stanford CTSA.
@ccos-ctsa.bsky.social

F Application Tips and Tricks Workshop Register here:https://ucdenverdata.formstack.com/forms/workshop F Application Tips and Tricks Workshop: Friday, January 16, 2026 | 9:00am-10:00am Location: P18-1006 Hensel Phelps West Auditorium…

Take our F Application Tips and Tricks Workshop before you craft your NRSA Fellowship application. Put your best foot forward! Workshop is on April 30.

@cupediatrics.bsky.social, @cudeptofmedicine.bsky.social, @cudivhospmed.bsky.social

Looking for funding, training, or ways to advance your research career? Our latest CCTSI newsletter highlights include a:
► T32 Fellowship
► Science Communication Workshop
► Community Engagement Showcase
👉 buff.ly/umDvBwR

Spotlight on the Rare Disease Advisory Council | News | CTSA CCOS <p><i>CCOS is pleased to continue our series of hub highlights, celebrating innovative contributions to clinical and translational science across the CTSA Program. Today, we spotlight the…

Research conducted at @CCTSI's Clinical Translational Research Center shows high‑intensity exercise can improve motor symptoms and may slow #Parkinson’s progression. Read more in our CTSA Hub Spotlight story!
@ccos-ctsa.bsky.social

The Pre-K Grant Review Program letter of intent is due TODAY! Apply to get expert feedback on your #NIH #grant submission.

📝 Apply here: buff.ly/UyEmR1V

@cudeptofmedicine.bsky.social, @childrensresearch.bsky.social

Running into #research roadblocks? Register for our Research Studio program! You will receive a 90-minute #consultation featuring three to five specially selected experts who will evaluate your research plan. 👉 buff.ly/sHKcXFI

🗓️ April 14 and May 26

Targeting Lynch Syndrome to Reduce Colorectal Cancer Risk New research into Lynch syndrome is leading to treatments and clinical trials that can help people with the diagnosis reduce their colorectal cancer risk.

Could a vaccine lower cancer risk for people with Lynch syndrome? A #clinical trial at our Clinical and Translational Research Center is exploring whether a preventive #vaccine could reduce colorectal cancer risk in people with this inherited condition.
@swatipatelmd.bsky.social

Frustrated with #grant applications? Let us help you get the funding your research deserves with our expert #NIH grant review programs and #funding opportunities! 👉 buff.ly/lwIchQ7

@cudeptofmedicine.bsky.social, @cupediatrics.bsky.social

The letter of intent for our Pre-R grant review program is due TODAY! Apply for CCTSI's Pre-R program to boost your odds of success for your #NIH #grant application.

Pre-R program info: buff.ly/JS3J4L9

@cupediatrics.bsky.social, @childrensresearch.bsky.social, @ccos-ctsa.bsky.social

Spring has sprung at the University of Colorado Anschutz! 🌸 We love seeing our colorful campus in bloom.

ACCORDS/CCTSI Community Engagement Showcase Join us for the 2026 ACCORDS/CCTSI Community Engagement Showcase, an event designed to bring together researchers, community partners, and stakeholders to strengthen collaboration and advance…

How can institutions support community-engaged research more ethically and effectively? Learn more at our April 24 Community Engagement Showcase. Come for the presentation, stay for the conversation! Co-hosted with @accordsresearch.bsky.social.
@cobioethics.bsky.social, @famdocdon.bsky.social

Kudos to four CCTSI program leaders recognized for excellence in #research, #mentorship, and leadership at @cuanschutz.bsky.social and nationally. We’re proud to work with Drs. Natalie Nokoff, Natalie Serkova, Janine Higgins & Paul MacLean. Congrats! 👏

@kmess44.bsky.social, @CCOS-CTSA.bsky.social

Colorado Pragmatic Research in Health Conference (COPRHCon)'s 2026 theme is Pragmatic Outcomes Research: Methods, Tools, and Technology for Rapidly Changing Contexts. Early bird pricing ends 4/1/2026.

No April Fools prank here--the early bird pricing for #COPRHCon26 really does fly away after April 1st!

Register Today to Maximize Your Savings: tinyurl.com/4pe57jbp

#PragmaticResearch #CUAnschutz #ACCORDSInnovation #ACCORDSIntegration #HealthServicesResearch

Yikes.

Compretta earns 2026 SEC Faculty Achievement Award The long-term commitment of Dr. Caroline Compretta, assistant vice chancellor for research, to health equity, community partnerships and research has landed her in the top echelon of academic achiever...

We're thrilled to announce that MCCTR Community Engagement and Outreach Core leader Dr. Caroline Compretta has received the 2026 Southeastern Conference Faculty Achievement Award!
umc.edu/news/News_Ar...

Communicating Your Science to the Public -  Registration This three-part series provides an overview of why and how to engage the public, everyone from television reporters to your neighbor and even with the world on social media

When you try to explain your research, do people look bored? Register for "Communicating Your Science to the Public" to learn how to tell a compelling story about what you do and why it is important! Starts May 8.
@cubiomedinfo.bsky.social, @cupediatrics.bsky.social, @cudeptofmedicine.bsky.social

When heart disease runs in the family, genetic testing can catch cardiomyopathy early Genetic testing found an FLNC gene mutation and a genetic disease of the heart muscle, leading to early treatment and a strong prognosis.

Genetic testing can save lives. A CCTSI study offered no-cost genetic testing, labs, and echocardiograms for families with genetic cardiomyopathy. This research helped detect disease early in individuals with a family history of heart disease.
▶️ buff.ly/nt09Duj
@cumedicine.bsky.social

📰 Our March monthly newsletter is here! Learn how the CCTSI is making a difference for individuals with Parkinson's disease. Sign up for trainings and events designed for early-career researchers!
▶️https://buff.ly/3OTTalT

@markharden.bsky.social, @accordsresearch.bsky.social

Spotlight on the Rare Disease Advisory Council | News | CTSA CCOS <p><i>CCOS is pleased to continue our series of hub highlights, celebrating innovative contributions to clinical and translational science across the CTSA Program. Today, we spotlight the…

We're proud to be featured in the @ccos-ctsa.bsky.social Hub Spotlight! CCTSI research shows high‑intensity exercise can improve motor symptoms and may slow Parkinson’s progression. The SPARX3 trial is helping establish exercise as first‑line therapy. #ResearchImpact
@cuanschutz.bsky.social

High Blood Pressure Deaths Quadruple Among Young Women, Study Finds FRIDAY, March 20, 2026 (HealthDay News) — High blood pressure-related deaths are skyrocketing among young women, with rates up more than fourfold during the pas

High blood pressure-related deaths are skyrocketing among young women, with rates up more than fourfold during the past two decades, a new study says.
www.healthday.com/health-news/...

CFSP Call for Applicants Helping emerging investigators obtain a career development award or a first independent, extramural project award through a variety of guided programs.

Are you an early-career investigator? Our Clinical Faculty Scholars Program offers mentorship, grant-writing support, and guidance to help you secure career development awards. Deadline to apply is March 20!
@cudeptofmedicine.bsky.social, @cupaccm.bsky.social

Improve your NIH #grant submission with the CCTSI's Pre-K and Pre-R grant review programs! They offer internal mock reviews and expert feedback to help you refine your submission.

Pre-K LOI due 4/13: buff.ly/uSpc9xN

Pre-R LOI due 4/2: buff.ly/Lx1HxIj

Can Ozempic Cure Addiction? GLP-1 drugs, which have helped some people curb drug and alcohol use, may unlock a pathway to moderation.

CCTSI researcher Joseph Schacht, PhD, led America's 1st randomized trial testing semaglutide (GLP‑1 meds like Ozempic) for heavy alcohol use at our Clinical Translational Research Center (CTRC) at @cuanschutz.bsky.social. Featured in the @newyorker.com!

If the White House doesn't nominate a person to serve as #CDC director by March 25, the administration will not be able to have someone serving in the role of acting CDC director.
⏰⏰⏰⏰⏰⏰⏰⏰

Check out this Q&A with innovator Dr. Richard Wang, professor and vice chair of research in Dermatology. Thanks for the @cctsi.bsky.social shout out, Dr. Wang! 😀
buff.ly/gqF2Kaq

ATLAS.ti Short Courses | CCTSI ATLAS.ti is qualitative data analysis software designed to help manage and analyze non-numerical data such as text, video, audio, and graphics.

Want to stand out in your field with strong qualitative #data analysis skills? Check out our ATLAS.ti (qualitative data analysis software) short course — perfect for those in medicine, nursing, public health and beyond.
@cudeptofmedicine.bsky.social, @childrensresearch.bsky.social

NIH Grant Aims to Improve Lifespan Care for Adults with Cerebral Palsy Cristina Sarmiento plans to use NIH grant award to adapt an online health tool to help guide the care of adults with cerebral palsy.

Cristina Sarmiento, MD, a former CCTSI Clinical Faculty Scholars participant, is developing an online tool to improve lifespan care for adults with cerebral palsy through personalized, CP‑informed guidance. #ResearchImpact

Matthew DeCamp, MD, PhD, Takes New Leadership Role at CCTSI Matthew DeCamp, MD, PhD, joins CCTSI as Associate Director for Community Engagement, enhancing ethical and community-focused research initiatives in Colorado.

We are pleased to announce that Matthew DeCamp, MD, PhD, has been named associate director of the CCTSI Community Engagement program! His expertise in research ethics and community-engaged scholarship will help strengthen partnerships across Colorado.
@cobioethics.bsky.social

Spotlight on the Rare Disease Advisory Council | News | CTSA CCOS <p><i>CCOS is pleased to continue our series of hub highlights, celebrating innovative contributions to clinical and translational science across the CTSA Program. Today, we spotlight the…

We're proud to be featured in the @ccos-ctsa.bsky.social Hub Spotlight! CCTSI research shows high‑intensity exercise can improve motor symptoms and may slow Parkinson’s progression. The SPARX3 trial is helping establish exercise as first‑line therapy. #ResearchImpact
@cuanschutz.bsky.social

CFSP Call for Applicants Helping emerging investigators obtain a career development award or a first independent, extramural project award through a variety of guided programs.

Ready to move from early-career researcher to independent investigator? Our Clinical Faculty Scholars Program (CFSP) is a 2‑year, mentored program that provides participants with mentorship, research training, grantsmanship support, and career planning.

Deadline: March 20, 2026